Meet the Proteona team at the 37th Annual J.P. Morgan HEALTHCARE CONFERENCE in San Francisco
Innovative genomic and proteomic analysis platform for Immuno-Oncology and Single Cell BioMedical Applications
SINGAPORE, 01 December 2018 - Proteona announced that Dr Andreas Schmidt, Chief Executive Officer, will be at the 37th Annual J.P. Morgan HEALTHCARE CONFERENCE in San Francisco from the 7th to the 10th January, 2019.
Dr Schmidt will be available during the conference to discuss the recent development in their ESCAPE™ RNA Sequencing technology, which allows for obtaining protein and gene expression information from the same single cells.
For media queries, please contact:
Dr Andreas Schmidt
Proteona Pte. Ltd. is a new biomedical company based in Singapore and San Diego that is pioneering the use of DNA barcoded antibodies to provide both proteomic and genomic information from the same single cells. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research’s (A*STAR). The platform is a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles.